Estrella Immunopharma Inc... (ESLA)
undefined
undefined%
At close: undefined
1.19
0.00%
After-hours Jan 07, 2025, 03:59 PM EST

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20
PE Ratio -5.3 -59.53 -34.71 -467.79
PS Ratio n/a n/a n/a n/a
PB Ratio 9.06 8.39 -56.26 n/a
P/FCF Ratio -2.41 -56.81 -40.57 -511.63
P/OCF Ratio -2.41 -56.81 -40.57 -511.63
OCF/S Ratio n/a n/a n/a n/a
Debt / Equity Ratio n/a 0.07 n/a n/a
Quick Ratio 24.65 0.05 5.20 n/a
Current Ratio 24.65 0.05 5.20 n/a
Asset Turnover n/a n/a n/a n/a
Interest Coverage n/a n/a n/a n/a
Return on Equity (ROE) -1.71 -0.14 1.62 n/a
Return on Assets (ROA) -1.64 -0.1 -0.34 n/a
Return on Capital (ROIC) -1.71 -0.18 -0.42 n/a
Dividend Yield n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a